Paydirt
BW
Insider

Bryan Wahl

General Counsel

Bryan Wahl (General Counsel) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $850K of TARS (12,440 sh across 3 lots, as filed), executed Mar 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$850K
shares × price, as filed
Last traded
Mar 19
Filed Mar 19

Median ADV $68.4M across their filed names

Open performance
Volume by month
$850K$425K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2025 · sells $464KMar 2026 · sells $850K
Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
TARS Tarsus Pharmaceuticals, Inc. TARS · 0 buys · 2 sells 2 filings
Recent filings
TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $850K
12,440 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET
TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $464K
9,686 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET